Mark Stephen, MD
Orthopedic Surgery · Levittown, NYNPI 1790772408
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,000 of the $3,543 with a category attached, or 84.7%. Stryker accounts for 89.3% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2022 at $3,022 and has fallen 99.1% since, to $27 in 2025.
Across 10 payments — averaging $354.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$3K
- Sanara Medtech Inc.$206
- Medtronic$64
- Intrinsic Therapeutics$58
- Stimwave Technologies Incorporated$50
What the payments were for
- Consulting fees$3,00085%
- Food & beverage$54315%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 5 | $3,165 |
| Sanara Medtech Inc. | 1 | $206 |
| Medtronic | 2 | $64 |
| Intrinsic Therapeutics | 1 | $58 |
| Stimwave Technologies Incorporated | 1 | $50 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVEREST SPINAL SYSTEM$3,000
- CellerateRx$206
How this compares
$3,543 in reported general payments places this provider in the 70th percentile of 91 orthopedic surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GraliseGabapentin | 16 | $6,203 |
| OxycontinOxycodone Hcl | 15 | $4,397 |
| Pregabalin | 96 | $2,649 |
| Oxycodone Hcl | 92 | $1,319 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 61 | $1,189 |
| Lidocaine | 12 | $1,136 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 32 | $888 |
| Methocarbamol | 78 | $535 |
| Methylprednisolone | 78 | $468 |
| Gabapentin | 60 | $466 |
| Meloxicam | 111 | $367 |
| Celecoxib | 21 | $293 |
| Cyclobenzaprine Hcl | 18 | $274 |
| Naproxen | 15 | $214 |
| Ibuprofen | 29 | $193 |
Paid to pharmacies, not to this prescriber.
Other orthopedic surgery in Levittown
- Robert CarterLevittown$474
- Carlos MonteroLevittown$172
- Baron LonnerNew York$2.1M
- Jan KoenigRockville Centre$1.4M
- Lon WeinerNew York$622K
- Andrew CappuccinoLockport$581K
- Douglas PadgettUniondale$407K
- James GladstoneNew York$260K
- Thomas WickiewiczNew York$201K
- David EssigNew York$123K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.